Scott Doncaster, Marc Sauer,
The development and production of mRNA therapeutics and vaccines requires expertise in both chemical synthesis and microbial fermentation. CDMOs with expertise in both are ideally positioned to ...
Prof. Dr. Ulrike Fiedler, Rob Burgess, Ph.D.,Amy Sheng, Ph.D., Lillith Elmore
The demand for vaccine, cell and gene therapeutics, and biologic manufacturing has increased dramatically in recent years, in part due to the need to produce billions of doses of COVID-19 ...
Aniruddha Bose
As biopharma manufacturing shifts from pre-digital processes to more digital ones, technology providers will develop intensified bioprocessing technologies together with software, automation, ...
David Alvaro, Ph.D.
Representatives from start-up development company Wheeler Bio and its digitalization partners, DataHow and Synthace, discuss how their collaboration will help Wheeler gain deeper insights into ...
Thilo Kamphausen, Ph.D., Kai Pohlmeyer
With 30 years of experience manufacturing plasmid DNA (pDNA), Richter-Helm has gained an unparalleled amount of first-hand knowledge that they apply to each customer project, regardless of phase ...
David Alvaro, Ph.D.
Representatives from start-up development company Wheeler Bio and its digitalization partners, DataHow and Synthace, discuss how their collaboration will help Wheeler gain deeper insights into ...
Amy Sheng, Ph.D., Rob Burgess, Ph.D.,Amy Sheng, Ph.D., Lillith Elmore
Demand for antibodies continues to rise as new drug targets are constantly being discovered and new formats that address the shortcomings of traditional monoclonal antibodies progress through ...
Atef Khezri
Process development and manufacturing for viral vectors intended for cell and gene therapies present unique quality and safety challenges requiring rigorous quality culture and systems and ...
Welcome to the first digital issue of the new Pharma’s Almanac, bringing our high levels of thought leadership into new spaces. This issue reflects an expansion of our editorial content, including regular columns from the Nice Insight and Pharma’s Almanac teams, in addition to some really illuminating Q&A interviews and articles on a range of innovative, forward-looking topics spanning drug discovery, development, and manufacturing. This issue includes some amazing contributors, so we hope you enjoy!
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac.
View Full Company Directory